DUBLIN, September 28, 2022 /PRNewswire/ — The report “Global Glaucoma treatment Market Research and Forecast 2022-2028” has been added to from ResearchAndMarkets.com offer.
The global glaucoma treatment market is expected to grow at a considerable CAGR of 5.2% during the forecast period (2021-2027). Glaucoma is one of the major eye disorders that damages the optic nerve and can lead to vision loss and blindness. Called a silent thief of sight, he shows no observed pain until a noticeable sight occurs.
Glaucoma is usually seen due to high intraocular pressure in people. It mainly occurs in people over the age of 40, but congenital glaucoma is also seen worldwide. The growth of the geriatric population is one of the main factors responsible for the increasing incidence of glaucoma. The incidence and prevalence rate of glaucoma disease is increasing at a significant rate across the world. According to the World Health Organization (WHO), in 2020, approximately 2.2 billion people worldwide suffered from one or another type of visual impairment and 80.0% of them were considered to be preventable.
The most common treatments for glaucoma are eye drops and, rarely, pills. However, advances in surgical treatment have spurred the growth of the application of ophthalmic laser in the treatment of glaucoma. There are different types of laser surgeries used to treat glaucoma, such as Selective Laser Trabeculoplasty (SLT), Argon Laser Trabeculoplasty (ALT), Laser Peripheral Iridotomy (LPI), and Laser Cyclophotocoagulation. lasers, among others.
Apart from this, the continuous innovations in medicines and the growing number of patients with diabetes have resulted in significant growth opportunities. Although some factors are hampering the growth of the market include a lack of awareness about the disease and its treatment in various regions, as well as postoperative complications resulting from glaucoma surgery. Growing glaucoma awareness initiatives and technological advancements are also creating opportunities for the glaucoma treatment market. In addition to this, the absence of pain and the absence of symptoms other than a noticeable vision are considered to be the challenge of the market.
Main topics covered:
1. Summary of the report
2. Overview and Market Overview
3. Competitive landscape
4. Market drivers
5. Market segmentation
6. Regional analysis
7. Company Profiles
Companies mentioned
- Aerie Pharmaceuticals, Inc.
- Akorn, Inc.
- Allergan AG
- Bausch & Lomb Pvt. ltd.
- Bayer AG
- Carl Zeiss AG
- F. Hoffmann-La Roche, Ltd.
- HOYA Corp.
- Inotek Corp.
- Ivantis, Inc.
- Johnson & Johnson Vision Care, Inc.
- Merck & Co., Inc.
- Novartis AG
- Pfizer, Inc.
- Regeneron Pharmaceuticals, Inc.
- Sanofi SA
- Santen Pharmaceuticals Co., Ltd.
- Teva Pharmaceuticals Industries, Ltd.
- Topcon Corp.
- Valeant Pharmaceuticals International, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/2zyk9t
Media Contact:
Research and Markets
Laura Woodsenior
[email protected]
For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900
US Fax: 646-607-1904
Fax (outside the US): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets